These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Clinical course and the effectiveness of conservative treatment of prolactin-secreting pituitary adenoma]. Sabakhtarashvili MA; Veĭnberg EG; Kurashvili RB; Kanchaveli ZSh Akush Ginekol (Mosk); 1989 Oct; (10):50-4. PubMed ID: 2618957 [TBL] [Abstract][Full Text] [Related]
4. [Hyperprolactinemia in patients with non-functioning adenoma: analysis of 85 patients treated by transsphenoidal operation]. Saitoh Y; Mori S; Arita N; Hayakawa T; Mogami H; Oku Y; Onishi T; Uozumi T No Shinkei Geka; 1987 Nov; 15(11):1175-9. PubMed ID: 3437926 [TBL] [Abstract][Full Text] [Related]
5. [Hyperprolactinemia]. König MP; Kopp P Schweiz Med Wochenschr; 1986 Mar; 116(9):265-70. PubMed ID: 3952483 [TBL] [Abstract][Full Text] [Related]
6. Pregnancy in the hyperprolactinaemic patient. Corenblum B; Taylor PJ Clin Reprod Fertil; 1986 Feb; 4(1):1-11. PubMed ID: 3085911 [TBL] [Abstract][Full Text] [Related]
7. [The results of using parlodel in hyperprolactinemia]. Mel'nichenko GA; Gitel' EP; Romantsova TI Probl Endokrinol (Mosk); 1990; 36(3):29-33. PubMed ID: 2395828 [TBL] [Abstract][Full Text] [Related]
8. The dominant role of increased intrasellar pressure in the pathogenesis of hypopituitarism, hyperprolactinemia, and headaches in patients with pituitary adenomas. Arafah BM; Prunty D; Ybarra J; Hlavin ML; Selman WR J Clin Endocrinol Metab; 2000 May; 85(5):1789-93. PubMed ID: 10843153 [TBL] [Abstract][Full Text] [Related]
10. Increased thyroid-stimulating hormone response to thyrotropin-releasing hormone in hyperprolactinemic women. Seki K; Kato K J Clin Endocrinol Metab; 1985 Dec; 61(6):1138-41. PubMed ID: 3932450 [TBL] [Abstract][Full Text] [Related]
11. [Pregnancy and hyperprolactinemia. Review of therapeutic measures apropos of a series of 35 patients]. Scherrer H; Turpin G; Darbois Y; Metzger J; de Gennes JL Ann Med Interne (Paris); 1986; 137(8):621-6. PubMed ID: 3566010 [TBL] [Abstract][Full Text] [Related]
16. Absence of growth hormone response to L-dopa and bromocriptine in hyperprolactinemic women with pituitary microadenoma. Seki K; Kato K; Shima K J Clin Endocrinol Metab; 1986 Apr; 62(4):783-4. PubMed ID: 3512593 [TBL] [Abstract][Full Text] [Related]
17. Effectiveness and tolerability of long term treatment with cabergoline, a new long-lasting ergoline derivative, in hyperprolactinemic patients. Ciccarelli E; Giusti M; Miola C; Potenzoni F; Sghedoni D; Camanni F; Giordano G J Clin Endocrinol Metab; 1989 Oct; 69(4):725-8. PubMed ID: 2570790 [TBL] [Abstract][Full Text] [Related]
18. Hyperprolactinemia: a 12-year retrospective study at gynecologic endocrinology unit, Siriraj Hospital. Saejong R; Dangrat C; Techatrisak K; Angsuwatthana S; Rattanachaiyanont M; Tanmahasamut P J Med Assoc Thai; 2013 Oct; 96(10):1247-56. PubMed ID: 24350404 [TBL] [Abstract][Full Text] [Related]
19. Hyperprolactinemia. Evaluation and management. Blackwell RE Endocrinol Metab Clin North Am; 1992 Mar; 21(1):105-24. PubMed ID: 1349524 [TBL] [Abstract][Full Text] [Related]
20. Hyperprolactinemia and impotence: why, when and how to investigate. Leonard MP; Nickel CJ; Morales A J Urol; 1989 Oct; 142(4):992-4. PubMed ID: 2795758 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]